P117: A sponsored genetic testing and counseling program for sensorineural hearing loss reduces barriers to genetic testing*

Over 60% of congenital sensorineural hearing loss (SNHL) cases are due to genetic causes, yet few eligible patients undergo genetic testing. A genetic diagnosis can provide insights into the likelihood of a syndromic condition, prognosis of disease progression, inheritance risks, and potential eligibility for gene therapy trials. However, barriers to testing include insurance reimbursement, patient costs, provider education gaps, availability of genetic services, and logistical challenges. Removing some of the key barriers to genetic testing for hearing loss will increase genetic testing utilization and facilitate earlier and more accurate diagnosis.